NLRP3 and type 2 diabetes mellitus: Consistent with relevance of this pathway in diabetes treatment, Il-1β, Nlrp3, and Asc gene expression is reduced after 1 year of weight loss in obese type 2 diabetic patients, and these gene expression changes were positively correlated with improvements in glycemia (Vandanmagsar et al., 2011).